Relypsa Revenue and Competitors
Estimated Revenue & Valuation
- Relypsa's estimated annual revenue is currently $13.9M per year.
- Relypsa's estimated revenue per employee is $155,000
- Relypsa's total funding is $656.6M.
Employee Data
- Relypsa has 90 Employees.
- Relypsa grew their employee count by -25% last year.
Relypsa Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Relypsa?
Relypsa, Inc. is a privately held biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease. The company’s most advanced therapeutic programs include a novel potassium binder for treatment of hyperkalemia, known as ILY-105, as well as a novel sodium binder, ILY102, for the potential treatment of congestive heart failure. Relypsa is dedicated to discover additional product candidates through use of its proprietary polymer platform. To date, Relypsa has raised $33 million in Series A financing. Investors include 5AM Ventures, New Leaf Venture Partners, Delphi Ventures, CMEA Ventures and Mediphase Venture Partners.
keywords:Biotechnology, Healthcare
$656.6M
Total Funding
90
Number of Employees
$13.9M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Relypsa's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Territory Account Manager | Reveal Email/Phone |
2 | Director | Reveal Email/Phone |
3 | Senior Division Sales Manager | Reveal Email/Phone |
4 | Territory Account Manager | Reveal Email/Phone |
5 | Senior Medical Director; Drug Safety and Pharmacovigilance | Reveal Email/Phone |
6 | Territory Account Manager | Reveal Email/Phone |
7 | Sr Salesforce/Veeva Consultant | Reveal Email/Phone |
8 | Territory Account Manager | Reveal Email/Phone |
Relypsa News
... his niche building early-stage commercial organizations at companies such as Oscient Pharmaceuticals, AMAG Pharmaceuticals and Relypsa.
Relypsa, Inc., a Santa Clara, CA-based biopharmaceutical company developing non-absorbed polymeric drugs, completed a $70m Series B financing. The round was led by OrbiMed Advisors, LLC, with participation from existing investors New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, Sprout ...
Pharmaceutical company Relypsa announced that its investors extended its first round of funding by $10 million to a total $43 million to help it finish phase-two clinical trials on its lead drug candidate, a treatment that could alleviate symptoms of heart failure and chronic kidney disease. Ba ...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.5M | 90 | -6% | N/A |
#2 | $12.7M | 91 | -1% | $48M |
#3 | $13.2M | 91 | 57% | $22.6M |
#4 | $14.3M | 92 | 0% | N/A |
#5 | $15.2M | 92 | 6% | N/A |
Relypsa Executives
| Name | Title |
|---|---|
| Sajani Mehta | CEO Founder |